personalized medicine
An approach that uses large data and knowledge of the physical basis of disease subtypes to tailor interventions to specific patients or disease subtypes.
As defined in Jacob Stegenga on Medical Nihilism
Other definitions
Medical practice that tailors treatment to individual patient characteristics (genetics, biomarkers, phenotypes) rather than applying population-average protocols uniformly
Peter Attia Dives Deep on STATINS (side effects & the best alternatives)
Where it comes up · 11
- Peter Attia Dives Deep on STATINS (side effects & the best alternatives)3 claims
- MIT Scientist on Unifying Cognition and Biology | Manolis Kellis2 claims
- Peter Attia – Live1 claim
- Investing in Healthcare1 claim
- Reid Hoffman and Ben Casnocha on LinkedIn and The Alliance1 claim
- Robert Aronowitz on Risky Medicine1 claim
- Adam Cifu on Ending Medical Reversal1 claim
- Jonathan Skinner on Health Care Costs, Technology, and Rising Mortality1 claim
and 3 more
Most important claims · 10 of 14Search all claims for “personalized medicine” →
- Gut bacteria can degrade medicines, so the same drug may work for some people and not others or cause side effects in some, and microbiome differences are a plausible explanation for this variability, which makes personalized medicine harder.361 | Bonnie Bassler on How Bacteria Talk and Work Together
- Personalized medicine using genetics holds enormous promise but increases the temptation to assume a drug works because of how it acts on a gene; because therapies will generalize to smaller and smaller groups, each must be tested on those small groups, making randomized trials and evidence-based medicine even more important rather than less.Adam Cifu on Ending Medical Reversal
- Personalized medicine is economically feasible only if treatments are modular: instead of one pill per patient (impossibly expensive), we need pills for each dysregulated pathway, where each pathway is shared by millions in different combinations, making economics viable through modular combinatorics.MIT Scientist on Unifying Cognition and Biology | Manolis Kellis
- Calling something like depression a 'complex disease' may mask our ignorance: depression might be a hundred distinct subtypes, which is why a handful of SSRIs fail to be clinically significant, and personalized medicine promises to sub-type diseases and tailor interventions accordingly.Jacob Stegenga on Medical Nihilism
- The coming avalanche of personalized genetic risk information (e.g., 23andMe results citing multiplied risks of diabetes or heart disease) will create a market for unproven interventions and unleash fear, so we may need a 'Rawlsian bargain' to withhold such information until we have good evidence about whether the interventions tied to it actually work—because even solid probability data without an effective intervention may not benefit people.Robert Aronowitz on Risky Medicine
- Engineerable synthetic cells could serve as a versatile, programmable platform to make small amounts of biomolecule drugs on demand, tailored to individual patients—useful for personalized medicine and especially for scenarios like long space missions to Mars where you cannot know in advance what drug an astronaut will need.56 | Kate Adamala on Creating Synthetic Life
- For each patient, you can measure their burden of dysregulation in every gene in each pathway using their own genome, then create a modular combination of therapeutics addressing their specific pattern of dysregulation—allowing personalized medicine at scale.MIT Scientist on Unifying Cognition and Biology | Manolis Kellis
- Medicine is transitioning from medicine 1.0, which mainly controls disease symptoms, to medicine 2.0, which aims to cure or prevent disease, and simultaneously from mass one-size-fits-all products to personalized medicine tailored to each patient's unique biology.Investing in Healthcare
- Tom DePriest recently gave an internal presentation (months in preparation) examining the relationship between statin use and desmosterol levels in relation to dementia risk, suggesting this is an important emerging area of personalized medicine analysisPeter Attia Dives Deep on STATINS (side effects & the best alternatives)
- The speaker describes this personalized, desmosterol-guided approach to statin management as 'personalized medicine 3.0,' requiring individual patient monitoring rather than population-level treatment algorithmsPeter Attia Dives Deep on STATINS (side effects & the best alternatives)